Tuesday, October 21, 2014 11:28:02 PM
The question is how do they get to 4?...........through appreciation of share price or RS?...............the prospectus said the 3.2(can't remember exact number) would be a loss..........kind of confused on how this whole deal works out..........the prospectus says it's a losing deal right from the get go, so who's going to invest?.........my guess is only if they can short their investment as a hedge knowing the share price will decline.........they made it seem like they didn't have a good place to put the money like some project that needed funding to create revenue in The short term, but instead were using it for "operations"..........kind of read like an OTC stock IMO..........so, I don't know what to make of it..................would be nice if they busted out a new deal PR........they just got FDA approval, correct?...........$$$
Learn how to analyze Charts & interpret Japanese candlestick patterns........link below...........$$$
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=86130044
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM